Design, synthesis and biological evaluation of gentiopicroside derivatives as potential antiviral inhibitors

Eur J Med Chem. 2017 Apr 21:130:308-319. doi: 10.1016/j.ejmech.2017.02.028. Epub 2017 Feb 21.

Abstract

Based on classical drug design theory, a novel series of gentiopicroside derivatives was designed and synthesized. All synthesized compounds were then biologically evaluated for their inhibition of influenza virus and anti-HCV activity in vitro. Some of the gentiopicroside derivatives, such as 11a, 13d and 16 showed interesting anti-influenza virus activity with IC50 at 39.5 μM, 45.2 μM and 44.0 μM, respectively. However, no significant anti-HCV activity was found for all of gentiopicroside derivatives. The preliminary results indicate that modification of the sugar moiety on gentiopicroside was helpful for enhancing the anti-influenza activities. Our works demonstrate the importance of secoiridoid natural products as new leads in the development of potential antiviral inhibitors.

Keywords: Anti-influenza virus; Antiviral agents; Gentiopicroside derivatives; Natural product; Secoiridoid.

MeSH terms

  • Animals
  • Antiviral Agents / chemical synthesis*
  • Antiviral Agents / pharmacology
  • Cell Line
  • Drug Design
  • Humans
  • Influenza, Human / drug therapy*
  • Influenza, Human / virology
  • Iridoid Glucosides / chemistry
  • Iridoid Glucosides / pharmacology*
  • Orthomyxoviridae / drug effects
  • Structure-Activity Relationship

Substances

  • Antiviral Agents
  • Iridoid Glucosides
  • gentiopicroside